Eligibility depends on your medical history and the circumstances of your Ozempic use
The medication is administered as a once-weekly subcutaneous injection and is intended to be used alongside a reduced-calorie diet and increased physical activity
Dietary modifications significantly reduce gastrointestinal symptoms: Eat smaller portions distributed throughout the day Choose lean proteins and complex carbohydrates Avoid high-fat, spicy, or heavily seasoned foods Stop eating when feeling satisfied, not full Separate liquid consumption from meals by 30 minutes Timing strategies help minimize discomfort
Some patients report that deep breathing during injection or distraction techniques (focusing on something else momentarily) reduce their perception of burning
These may result from changes in blood flow or mild dehydration caused by the medication
Misleading marketing FDA has sent warning letters to more than 80 compounders and telehealth companies over misleading GLP-1 advertising, including 30 telehealth firms in a single 2026 action, following more than 50 letters in 2025